Rapid and reproducible radiosynthesis of [18F] FHBG
Introduction
9-(4-[18F] Fluoro-3-hydroxymethylbutyl) guanine ([18F] FHBG) [(3) Scheme 1] has been used as a reporter probe to image the expression of the herpes simplex virus type 1 thymidine kinase (HSV1-tk) reporter gene in living organisms [1], [2]. HSV1-tk phosphorylates [18F] FHBG to its monophosphate form, leading to intracellular accumulation [3]. Cellular retention of radioactivity is, therefore, an indicator of HSV1-tk gene expression. When HSV1-tk is linked to another (e.g. therapeutic) transgene, the accumulation of [18F] FHBG in tissues can be used to measure the magnitude, location and timing of expression of the target transgene. Positron emission tomography (PET) has been used successfully in conjunction with [18F] FHBG to assess gene expression in vivo. Eventually, use of these methods may be useful in the planning of gene therapy in humans.
Various research groups have presented methods for the radiosynthesis of [18F] FHBG [4], [5], [6]. As the use of [18F] FHBG increases, there is a need to develop more efficient approaches for its radiosynthesis. In order to shorten the synthesis time and thereby increase the yield, we have developed a method for the radiosynthesis of [18F] FHBG using a custom-designed microwave cavity (MWC) [7]. There are advantages of microwave heating other than time gain, such as a cleaner reaction mixture due to decreased sample decomposition and improved chemical flexibility due to the ability of microwaves to accelerate typically sluggish reactions of less activated substrates. Since our group first reported the use of a commercial microwave to shorten reaction times for short-lived radiolabeled pharmaceuticals [8], the application of microwave heating has grown in popularity [9], [10], [11]. In the current study, we have applied heating with a microwave cavity [7] to shorten the synthesis time and improve the radiochemical yield.
At our institution, demand for [18F] FHBG (2-4 times per week) is currently focused on studies of pulmonary gene expression in rodents using an enhanced mutant of HSV1-tk as the PET reporter gene. Typically, these studies show a low level of radiotracer uptake by the lungs, and thus require a radioactive tracer with very high radiochemical purity and with very low levels of free fluoride. We report here the details of the radiosynthesis of [18F] FHBG based on this MWC method and our improved solid-phase purification (SP) approach for the final product, by exchanging the commonly used C18 Sep-Pak for the more efficient Oasis® HLB (Hydrophilic-Lipophilic Balance) media.
Section snippets
General
Unless otherwise stated, all chemicals were obtained from Aldrich Chemical Co. (Sigma-Aldrich, St. Louis, MO) and used without further purification. N2, monomethoxytrityl-9-[4-(tosyl)-3-monomethoxytrityl-methylbutyl] guanine the precursor of [18F] FHBG, was purchased from PETnet Pharmaceuticals Inc, USA. H218O was purchased from Rotem Industries (Israel). Materials were heated using a custom-designed microwave cavity, model 420BX (Micro-Now Instruments, Skokie, IL) [7]. Screw cap test tubes
Results and discussion
The microwave-mediated, one-pot, two-step radiosynthesis afforded [18F] FHBG with an overall radiochemical yield of 12 ± 5% (n = 35) in a synthesis time of 55-60 min (Scheme 1).
N2, monomethoxytrityl-9-[4-(tosyl)-3-monomethoxytrityl-methylbutyl] guanine (1) was chosen as the precursor for F-18 labeling. In our preliminary work, we tried conventional heating in either DMSO or acetonitrile, but contrary to reported methods [4], [5], [6], our incorporation yields into intermediate 2 as analyzed by
Conclusion
In this study we have developed a rapid and reproducible method for the radiosynthesis of [18F] FHBG. Thus, [18F] FHBG can be easily prepared starting from N2, monomethoxytrityl-9-[4-(tosyl)-3-monomethoxytrityl-methylbutyl] guanine in 60 min. Microwave cavity irradiation, on the other hand, increases the reaction rate, and at the same time increases the labeling yield. Successive solid-phase purifications just before the final HPLC purification give [18F] FHBG >99% radiochemically pure and
Acknowledgements
We thank Bill Margenau for the cyclotron operation and Terry Sharp, Lynne Jones, Nicole Mercer, John Engelbach, Jean-Christophe Richard and Jim Koslowski for microPET imaging experiments. This work was supported by NIH grant HL 32815.
References (18)
- et al.
Imaging gene expressionPrinciples and assays
J Nucl Cardiol
(1999) - et al.
Metabolism of 9-(1, 3-dihydroxy-2-propoxymethyl) guanine, a new anti-herpes virus compound in herpes simplex virus infected cells
J Biol Chem
(1983) - et al.
Synthesis and preliminary evaluation 9-(4-[18F] fluoro-3-hydroxymethylbutyl) guanine ([18F] FHBG)A new potential imaging agent for viral infection and gene therapy using PET
Nucl Med Biol
(1998) - et al.
A simplified one-pot synthesis of 9-[(3-[18F] Fluoro-1-hydroxy-2-propoxy) methyl] guanine ([18F] FHPG) and 9-(4-[18F] Fluoro-3-hydroxymethylbutyl) guanine ([18F] FHBG) for gene therapy
Nucl Med Biol
(2001) - et al.
Application of microwave heating to the synthesis of [F-18] Fluoromisonidazole
Appl Radiat Isot
(1993) - et al.
No-carrier-added synthesis of 3-[18F] fluoro-1-(2-nitro-1-imidazolyl)-2-propanol, a potential PET agent for detecting hypoxic but viable tissues
Appl Radiat Isot
(1989) - et al.
Imaging adenoviral directed reporter gene expression in living animals with positron emission tomography
Proc Natl Acad Sci USA
(1999) - et al.
Human pharmacokinetic and dosimetry studies of [18F] FHBGA reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression
J Nucl Med
(2001) - et al.
Evaluation of a microwave cavity for the synthesis of PET radiopharmaceuticals
J Label Compd Radiopharm
(1995)
Cited by (44)
Efficient synthesis of 9-(4-[<sup>18</sup>F]fluoro-3-hydroxymethylbutyl)guanine ([<sup>18</sup>F]FHBG) and 9-[(3-[<sup>18</sup>F]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([<sup>18</sup>F]FHPG)
2017, Journal of Fluorine ChemistryCitation Excerpt :The importance and usefulness of [18F]FHBG as a PET imaging agent for monitoring gene expression in cancer gene therapy in humans is further underscored by its recent US Food and Drug Administration (FDA) approval as an investigational new drug (IND) [17]. The synthesis of [18F]FHPG [18–23] and [18F]FHBG [19,20,22–31] have been well described in the literature. However, many of these methods provide low radiochemical yields and/or suffer from reproducibility related issues.
A multimodality reporter gene for monitoring transplanted stem cells
2012, Nuclear Medicine and BiologyCitation Excerpt :The mixture was then diluted with H2O and purified with a Sep-Pak C-18 column. The radiolabeled yield and radiochemical purity of 18F-FHBG were measured using high- performance liquid chromatography and TLC as previously described [31]. In the time-dependent uptake experiment, the Ad5-TGF-transfected cells (MOI=100) served as the experimental group, and the Ad5-eGFP-transfected cells (MOI=100) served as the control group.
Comparison of two full automatic synthesis methods of 9-(4-[<sup>18</sup>F]fluoro-3-hydroxymethylbutyl)guanine using different chemistry modules
2009, Applied Radiation and IsotopesAntigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma
2023, Journal of Nuclear Medicine